https://huskerchem.com/index.p....hp/microsurgical-dre
We previously reported that DISC1 kinds a protein complex with dopamine D2 receptor (D2R), the key target for antipsychotic medications. The D2R-DISC1 complex is elevated in mind structure from schizophrenia patients and facilitates glycogen synthase kinase (GSK)-3 signaling. The DISC1 R264Q variation is found within the area that binds the D2R, and we found that this polymorphism advances the affinity of DISC1 when it comes to D2R and promotes GSK3 task. Our outcomes suggest a poss
Like
Comment
Share
